|
2022
|
Invention
|
Applications of ghr-106 monoclonal antibody as a gnrh antagonist.
GHR-106 monoclonal antibody or... |
|
|
Invention
|
Applications of ghr-106 monoclonal antibody as a gnrh antagonist. GHR-106 monoclonal antibody or ... |
|
2020
|
Invention
|
Method of inhibiting the gonadotropin-releasing hormone (gnrh) receptor by administering a ghr-10... |
|
2019
|
Invention
|
Use of ghr-106 monoclonal antibody as a gnrh antagonist. An antibody-based GnRH receptor antagoni... |
|
2014
|
Invention
|
Humanized antibodies to ca215.
Provided herein are humanized forms of murine RP215 monoclonal an... |
|
2013
|
Invention
|
Humanized antibodies to ca215. Provided herein are humanized forms of murine RP215 monoclonal ant... |
|
|
Invention
|
Humanized forms of monoclonal antibodies to human gnrh receptor. Humanized forms of murine GHR106... |
|
2012
|
Invention
|
Monoclonal antibodies against gonadotropin-releasing hormone receptor. Monoclonal antibodies agai... |
|
|
Invention
|
Carbohydrate-containing pan cancer marker.
The effective epitope of CA215, a known cancer marker... |
|
2011
|
Invention
|
Carbohydrate hapten-based anti-cancer vaccines and antibody drugs.
Immunogenic compositions that... |
|
|
Invention
|
Carbohydrate hapten-based anti-cancer vaccines and antibody drugs. Immunogenic compositions that ... |
|
2008
|
Invention
|
Carbohydrate-containing pan cancer marker. The effective epitope of CA215, a known cancer marker ... |
